D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AVTX holding history
Avalo Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −17,307−100.0% | Sold outConverted for a 1-for-12 split | Holders |
| Q2 2022 | 207,683 | $104.0K | <0.1% | −112,679−35.2% | Reduced | Holders |
| Q1 2022 | 320,362 | $232.0K | <0.1% | −14,660−4.4% | Reduced | Holders |
| Q4 2021 | 335,022 | $570.0K | <0.1% | +161,598+93.2% | Added | Holders |
| Q3 2021 | 173,424 | $378.0K | <0.1% | +154,186+801.5% | Added | Holders |
| Q2 2021 | 19,238 | $63.0K | <0.1% | +19,238 | New | Holders |